{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:56:36Z","timestamp":1787860596437,"version":"build-2784847793"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1177\/1933719111430993","type":"journal-article","created":{"date-parts":[[2012,4,26]],"date-time":"2012-04-26T00:27:28Z","timestamp":1335400048000},"page":"674-683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Endometrial Abnormality in Women With Polycystic Ovary Syndrome"],"prefix":"10.1007","volume":"19","author":[{"given":"Kewei","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youfei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,30]]},"reference":[{"issue":"13","key":"1907674_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199509283331307","volume":"333","author":"S Franks","year":"1995","unstructured":"Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333(13):853\u2013861","journal-title":"N Engl J Med"},{"issue":"4","key":"1907674_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219\u2013231","journal-title":"Nat Rev Endocrinol"},{"key":"1907674_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","volume":"29","author":"IF Stein","year":"1935","unstructured":"Stein IF, Leventhal ML. Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181\u2013191","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1907674_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1210\/jcem-50-1-113","volume":"50","author":"GA Burghen","year":"1980","unstructured":"Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980;50(1):113\u2013116","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1907674_CR5","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1210\/jc.2005-2501","volume":"91","author":"S Franks","year":"2006","unstructured":"Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab. 2006;91(3):786\u2013789","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1907674_CR6","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91(11):4237\u20134245","journal-title":"J Clin Endocrinol Metab"},{"key":"1907674_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/IJWH.S11304","volume":"3","author":"A Badawy","year":"2011","unstructured":"Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Womens Health. 2011;3:25\u201335","journal-title":"Int J Womens Health"},{"issue":"2","key":"1907674_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1055\/s-0031-1272476","volume":"29","author":"RL Flyckt","year":"2011","unstructured":"Flyckt RL, Goldberg JM. Laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome. Semin Reprod Med. 2011;29(2):138\u2013146","journal-title":"Semin Reprod Med"},{"issue":"6","key":"1907674_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.rbmo.2011.03.013","volume":"22","author":"H Fernandez","year":"2011","unstructured":"Fernandez H, Morin-Surruca M, Torre A, et al. Ovarian drilling for surgical treatment of polycystic ovarian syndrome: a comprehensive review. Reprod Biomed Online. 2011;22(6):556\u2013568","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"1907674_CR10","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.fertnstert.2011.06.067","volume":"96","author":"E de Paula Guedes Neto","year":"2011","unstructured":"de Paula Guedes Neto E, Savaris RF, von Eye Corleta H, et al. Prospective, randomized comparison between raloxifene and clomiphene citrate for ovulation induction in polycystic ovary syndrome. Fertil Steril. 2011;96(3):769\u2013773","journal-title":"Fertil Steril"},{"issue":"1","key":"1907674_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.fertnstert.2009.03.014","volume":"94","author":"SY Zhao","year":"2010","unstructured":"Zhao SY, Qiao J, Chen YJ, et al. Expression of growth differentiation factor-9 and bone morphogenetic protein-15 in oocytes and cumulus granulosa cells of patients with polycystic ovary syndrome. Fertil Steril. 2010;94(1):261\u2013267","journal-title":"Fertil Steril"},{"issue":"2","key":"1907674_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/09513590.2010.490608","volume":"27","author":"G Zhong","year":"2011","unstructured":"Zhong G, Chen B. Serum and follicular fluid levels of IGF-II, IGF-binding protein-4 and pregnancy-associated plasma protein-A in controlled ovarian hyperstimulation cycle between polycystic ovarian syndrome (PCOS) and non-PCOS women. Gynecol Endocrinol. 2011;27(2):86\u201390","journal-title":"Gynecol Endocrinol"},{"issue":"7","key":"1907674_CR13","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1345\/aph.1M096","volume":"43","author":"KR Eckmann","year":"2009","unstructured":"Eckmann KR, Kockler DR. Aromatase inhibitors for ovulation and pregnancy in polycystic ovary syndrome. Ann Pharmacother. 2009;43(7):1338\u20131346","journal-title":"Ann Pharmacother"},{"issue":"4","key":"1907674_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1472-6483(10)60128-9","volume":"18","author":"VT Lan","year":"2009","unstructured":"Lan VT, Norman RJ, Nhu GH, Tuan PH, Tuong HM. Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome. Reprod Biomed Online. 2009;18(4):516\u2013521","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"1907674_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/humupd\/dmn015","volume":"14","author":"S Franks","year":"2008","unstructured":"Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008;14(4):367\u2013378","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1907674_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/humupd\/dmq032","volume":"17","author":"J Qiao","year":"2011","unstructured":"Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2011;17(1):17\u201333","journal-title":"Hum Reprod Update"},{"issue":"2","key":"1907674_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12020-011-9495-9","volume":"40","author":"W Hu","year":"2011","unstructured":"Hu W, Qiao J. Expression and regulation of adipocyte fatty acid binding protein in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome. Endocrine. 2011;40(2):196\u2013202","journal-title":"Endocrine"},{"issue":"11","key":"1907674_CR18","first-page":"4047","volume":"85","author":"CA Eagleson","year":"2000","unstructured":"Eagleson CA, Gingrich MB, Pastor CL, et al. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab. 2000;85(11):4047\u20134052","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1907674_CR19","first-page":"2108","volume":"82","author":"DA Ehrmann","year":"1997","unstructured":"Ehrmann DA, Schneider DJ, Sobel BE, et al. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82(7):2108\u20132116","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1907674_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1055\/s-2007-992927","volume":"26","author":"CM Boomsma","year":"2008","unstructured":"Boomsma CM, Fauser BC, Macklon NS. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med. 2008;26(1):72\u201384","journal-title":"Semin Reprod Med"},{"issue":"6","key":"1907674_CR21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/oxfordjournals.humrep.a138174","volume":"8","author":"AH Balen","year":"1993","unstructured":"Balen AH, Tan SL, MacDougall J, Jacobs HS. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod. 1993;8(6):959\u2013964","journal-title":"Hum Reprod"},{"issue":"4","key":"1907674_CR22","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0015-0282(98)00007-7","volume":"69","author":"MA Okon","year":"1998","unstructured":"Okon MA, Laird SM, Tuckerman EM, Li TC. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil Steril. 1998;69(4):682\u2013690","journal-title":"Fertil Steril"},{"issue":"6","key":"1907674_CR23","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/humrep\/16.6.1086","volume":"16","author":"P Fedorcsak","year":"2001","unstructured":"Fedorcsak P, Dale PO, Storeng R, Tanbo T, Abyholm T. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome. Hum Reprod. 2001;16(6):1086\u20131091","journal-title":"Hum Reprod"},{"issue":"1","key":"1907674_CR24","first-page":"89","volume":"7","author":"K Niwa","year":"2000","unstructured":"Niwa K, Imai A, Hashimoto M, et al. A case-control study of uterine endometrial cancer of pre- and post-menopausal women. Oncol Rep. 2000;7(1):89\u201393","journal-title":"Oncol Rep"},{"issue":"3","key":"1907674_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1472-6483(10)60228-3","volume":"17","author":"J Qiao","year":"2008","unstructured":"Qiao J, Wang L, Li R, Zhang X. Microarray evaluation of endometrial receptivity in Chinese women with polycystic ovary syndrome. Reprod Biomed Online. 2008;17(3):425\u2013435","journal-title":"Reprod Biomed Online"},{"issue":"12","key":"1907674_CR26","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.1210\/jc.2010-0603","volume":"95","author":"L Margarit","year":"2010","unstructured":"Margarit L, Taylor A, Roberts MH, et al. MUC1 as a discriminator between endometrium from fertile and infertile patients with PCOS and endometriosis. J Clin Endocrinol Metab. 2010;95(12):5320\u20135329","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1907674_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1095\/biolreprod66.2.297","volume":"66","author":"KB Apparao","year":"2002","unstructured":"Apparao KB, Lovely LP, Gui Y, Lininger RA, Lessey BA. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod. 2002;66(2):297\u2013304","journal-title":"Biol Reprod"},{"issue":"2","key":"1907674_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.beem.2006.03.005","volume":"20","author":"LC Giudice","year":"2006","unstructured":"Giudice LC. Endometrium in PCOS: Implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006;20(2):235\u2013244","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"1907674_CR29","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1093\/humrep\/dei420","volume":"21","author":"OC Pillay","year":"2006","unstructured":"Pillay OC, Te Fong LF, Crow JC, et al. The association between polycystic ovaries and endometrial cancer. Hum Reprod. 2006;21(4):924\u2013929","journal-title":"Hum Reprod"},{"key":"1907674_CR30","volume-title":"Textbook of Medical Physiology","author":"C Arthur","year":"2002","unstructured":"Arthur C, Guyton JEH. Textbook of Medical Physiology. 10th ed. Singapore: Health Sciences Asia, Elsevier Science; 2002.","edition":"10th"},{"issue":"2","key":"1907674_CR31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ejogrb.2006.01.023","volume":"127","author":"G Iatrakis","year":"2006","unstructured":"Iatrakis G, Tsionis C, Adonakis G, et al. Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium. Eur J Obstet Gynecol Reprod Biol. 2006;127(2):218\u2013221","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"1907674_CR32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jpag.2009.07.002","volume":"23","author":"B Shah","year":"2010","unstructured":"Shah B, Parnell L, Milla S, Kessler M, David R. Endometrial thickness, uterine, and ovarian ultrasonographic features in adolescents with polycystic ovarian syndrome. J Pediatr Adolesc Gynecol. 2010;23(3):146\u2013152","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"1907674_CR33","first-page":"325","volume":"98","author":"AP Cheung","year":"2001","unstructured":"Cheung AP. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome. Obstet Gynecol. 2001;98(2):325\u2013331","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1907674_CR34","first-page":"59","volume":"26","author":"N Peri","year":"2007","unstructured":"Peri N, Levine D. Sonographic evaluation of the endometrium in patients with a history or an appearance of polycystic ovarian syndrome. Ja Ultrasound Med. 2007;26(1):55\u201358; quiz 59\u201360","journal-title":"Ja Ultrasound Med"},{"issue":"2","key":"1907674_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/09513590600585997","volume":"22","author":"Y Tingthanatikul","year":"2006","unstructured":"Tingthanatikul Y, Choktanasiri W, Rochanawutanon M, Weerakeit S. Prevalence and clinical predictors of endometrial hyperplasiain anovulatory women presenting with amenorrhea. Gynecol Endocrinol. 2006;22(2):101\u2013105","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"1907674_CR36","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.fertnstert.2011.04.022","volume":"95","author":"BA McCormick","year":"2011","unstructured":"McCormick BA, Wilburn RD, Thomas MA, et al. Endometrial thickness predicts endometrial hyperplasia in patients with polycystic ovary syndrome. Fertil Steril. 2011;95(8):2625\u20132627","journal-title":"Fertil Steril"},{"issue":"1","key":"1907674_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ygyno.2006.03.029","volume":"103","author":"A Villavicencio","year":"2006","unstructured":"Villavicencio A, Bacallao K, Avellaira C, et al. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia. Gynecol Oncol. 2006;103(1):307\u2013314","journal-title":"Gynecol Oncol"},{"issue":"4","key":"1907674_CR38","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.maturitas.2008.12.018","volume":"62","author":"AE Schindler","year":"2009","unstructured":"Schindler AE. Progestogen deficiency and endometrial cancer risk. Maturitas. 2009;62(4):334\u2013337","journal-title":"Maturitas"},{"issue":"3","key":"1907674_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ijc.11529","volume":"108","author":"A Lukanova","year":"2004","unstructured":"Lukanova A, Lundin E, Micheli A, et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer. 2004;108(3):425\u2013432","journal-title":"Int J Cancer"},{"issue":"1","key":"1907674_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1055\/s-2007-992926","volume":"26","author":"R Navaratnarajah","year":"2008","unstructured":"Navaratnarajah R, Pillay OC, Hardiman P. Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med. 2008;26(1):62\u201371","journal-title":"Semin Reprod Med"},{"issue":"2","key":"1907674_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/gyno.1997.4656","volume":"65","author":"I Konishi","year":"1997","unstructured":"Konishi I, Koshiyama M, Mandai M, et al. Increased expression of LH\/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women. Gynecol Oncol. 1997;65(2):273\u2013280","journal-title":"Gynecol Oncol"},{"issue":"6","key":"1907674_CR42","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/S0002-9378(87)80258-2","volume":"157","author":"JF Randolph Jr","year":"1987","unstructured":"Randolph JF Jr, Kipersztok S, Ayers JW, et al. The effect of insulin on aromatase activity in isolated human endometrial glands and stroma. Am J Obstet Gynecol. 1987;157(6):1534\u20131539","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"1907674_CR43","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1210\/jc.2004-1676","volume":"90","author":"RB Lathi","year":"2005","unstructured":"Lathi RB, Hess AP, Tulac S, et al. Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways. J Clin Endocrinol Metab. 2005;90(3):1599\u20131606","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1907674_CR44","first-page":"363","volume":"86","author":"L Bermont","year":"2001","unstructured":"Bermont L, Lamielle F, Lorchel F, et al. Insulin up-regulates vascular endothelial growth factor and stabilizes its messengers in endometrial adenocarcinoma cells. J Clin Endocrinol Metab. 2001;86(1):363\u2013368","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1907674_CR45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0002-9378(98)70244-3","volume":"179","author":"M Nagamani","year":"1998","unstructured":"Nagamani M, Stuart CA. Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture. Am J Obstet Gynecol. 1998;179(1):6\u201312","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1907674_CR46","first-page":"112","volume":"131","author":"MF Press","year":"1988","unstructured":"Press MF, Udove JA, Greene GL. Progesterone receptor distribution in the human endometrium. Analysis using monoclonal antibodies to the human progesterone receptor. Am J Pathol. 1988;131(1):112\u2013124","journal-title":"Am J Pathol"},{"issue":"1","key":"1907674_CR47","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0301-2115(00)00554-6","volume":"98","author":"HJ Mertens","year":"2001","unstructured":"Mertens HJ, Heineman MJ, Theunissen PH, de Jong FH, Evers JL. Androgen, estrogen and progesterone receptor expression in the human uterus during the menstrual cycle. Eur J Obstet Gynecol Reprod Biol. 2001;98(1):58\u201365","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"1907674_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.acthis.2004.02.005","volume":"106","author":"I Mylonas","year":"2004","unstructured":"Mylonas I, Jeschke U, Shabani N, et al. Immunohistochemical analysis of estrogen receptor alpha, estrogen receptor beta and progesterone receptor in normal human endometrium. Acta Histochem. 2004;106(3):245\u2013252","journal-title":"Acta Histochem"},{"issue":"7","key":"1907674_CR49","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.fertnstert.2011.02.051","volume":"95","author":"MK Mehasseb","year":"2011","unstructured":"Mehasseb MK, Panchal R, Taylor AH, et al. Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis. Fertil Steril. 2011;95(7):2228\u20132235, 2235 e1","journal-title":"Fertil Steril"},{"issue":"2","key":"1907674_CR50","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1210\/jcem-67-2-334","volume":"67","author":"BA Lessey","year":"1988","unstructured":"Lessey BA, Killam AP, Metzger DA, et al. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab. 1988;67(2):334\u2013340","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 4","key":"1907674_CR51","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0015-0282(02)02985-0","volume":"77","author":"HG Burger","year":"2002","unstructured":"Burger HG. Androgen production in women. Fertil Steril. 2002;77(suppl 4):S3\u2013S5","journal-title":"Fertil Steril"},{"issue":"1\u20132","key":"1907674_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jsbmb.2011.02.001","volume":"125","author":"S Chumsri","year":"2011","unstructured":"Chumsri S, Howes T, Bao T, Sabnis G, Brodie A. Aromatase, aromatase inhibitors, and breast cancer. J Steroid Biochem Mol Biol. 2011;125(1\u20132):13\u201322","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1\u20132","key":"1907674_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jsbmb.2008.03.031","volume":"110","author":"K Bacallao","year":"2008","unstructured":"Bacallao K, Leon L, Gabler F, et al. In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia. J Steroid Biochem Mol Biol. 2008;110(1\u20132):163\u2013169","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"1907674_CR54","first-page":"593","volume":"19","author":"H Sasano","year":"1998","unstructured":"Sasano H, Harada N. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocr Rev. 1998;19(5):593\u2013607","journal-title":"Endocr Rev"},{"issue":"6058","key":"1907674_CR55","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/320134a0","volume":"320","author":"S Green","year":"1986","unstructured":"Green S, Walter P, Kumar V, et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 1986;320(6058):134\u2013139","journal-title":"Nature"},{"issue":"12","key":"1907674_CR56","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1073\/pnas.93.12.5925","volume":"93","author":"GG Kuiper","year":"1996","unstructured":"Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996;93(12):5925\u20135930","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1907674_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0014-5793(96)00782-X","volume":"392","author":"S Mosselman","year":"1996","unstructured":"Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996;392(1):49\u201353","journal-title":"FEBS Lett"},{"key":"1907674_CR58","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1146\/annurev.physiol.67.040403.115914","volume":"67","author":"SC Hewitt","year":"2005","unstructured":"Hewitt SC, Harrell JC, Korach KS. Lessons in estrogen biology from knockout and transgenic animals. Annu Rev Physiol. 2005;67:285\u2013308","journal-title":"Annu Rev Physiol"},{"issue":"suppl 2","key":"1907674_CR59","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S0015-0282(03)00987-7","volume":"80","author":"M Maliqueo","year":"2003","unstructured":"Maliqueo M, Clementi M, Gabler F, et al. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil Steril. 2003;80(suppl 2):812\u2013819","journal-title":"Fertil Steril"},{"issue":"4","key":"1907674_CR60","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.fertnstert.2005.09.053","volume":"85","author":"S Quezada","year":"2006","unstructured":"Quezada S, Avellaira C, Johnson MC, et al. Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome. Fertil Steril. 2006;85(4):1017\u20131026","journal-title":"Fertil Steril"},{"issue":"6","key":"1907674_CR61","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1210\/jcem.87.6.8572","volume":"87","author":"CW Gregory","year":"2002","unstructured":"Gregory CW, Wilson EM, Apparao KB, et al. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clin Endocrinol Metab. 2002;87(6):2960\u20132966","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1907674_CR62","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/09513590.2010.487584","volume":"27","author":"A Wang","year":"2011","unstructured":"Wang A, Ji L, Shang W, et al. Expression of GPR30, ERalpha and ERbeta in endometrium during window of implantation in patients with polycystic ovary syndrome: a pilot study. Gynecol Endocrinol. 2011;27(4):251\u2013255","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"1907674_CR63","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/er.2004-0003","volume":"26","author":"MJ Reed","year":"2005","unstructured":"Reed MJ, Purohit A, Woo LW, Newman SP, Potter BV. Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr Rev. 2005;26(2):171\u2013202","journal-title":"Endocr Rev"},{"issue":"5","key":"1907674_CR64","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1210\/er.2001-0040","volume":"23","author":"CA Strott","year":"2002","unstructured":"Strott CA. Sulfonation and molecular action. Endocr Rev. 2002;23(5):703\u2013732","journal-title":"Endocr Rev"},{"issue":"1","key":"1907674_CR65","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.steroids.2007.09.003","volume":"73","author":"L Leon","year":"2008","unstructured":"Leon L, Bacallao K, Gabler F, et al. Activities of steroid metabolic enzymes in secretory endometria from untreated women with Polycystic Ovary Syndrome. Steroids. 2008;73(1):88\u201395","journal-title":"Steroids"},{"issue":"1","key":"1907674_CR66","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/01.AOG.0000269047.46078.28","volume":"110","author":"SD MacLaughlan","year":"2007","unstructured":"MacLaughlan SD, Palomino WA, Mo B, et al. Endometrial expression of Cyr61: a marker of estrogenic activity in normal and abnormal endometrium. Obstet Gynecol. 2007;110(1):146\u2013154","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1907674_CR67","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/humupd\/dmn044","volume":"15","author":"B Gellersen","year":"2009","unstructured":"Gellersen B, Fernandes MS, Brosens JJ. Non-genomic progesterone actions in female reproduction. Hum Reprod Update. 2009;15(1):119\u2013138","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1907674_CR68","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/1933719110382922","volume":"18","author":"S Mesiano","year":"2011","unstructured":"Mesiano S, Wang Y, Norwitz ER. Progesterone receptors in the human pregnancy uterus: do they hold the key to birth timing? Reprod Sci. 2011;18(1):6\u201319","journal-title":"Reprod Sci"},{"issue":"10\u201313","key":"1907674_CR69","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0039-128X(03)00129-6","volume":"68","author":"SA Leonhardt","year":"2003","unstructured":"Leonhardt SA, Boonyaratanakornkit V, Edwards DP. Progesterone receptor transcription and non-transcription signaling mechanisms. Steroids. 2003;68(10\u201313):761\u2013770","journal-title":"Steroids"},{"issue":"1","key":"1907674_CR70","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1677\/joe.1.06242","volume":"187","author":"MS Fernandes","year":"2005","unstructured":"Fernandes MS, Pierron V, Michalovich D, et al. Regulated expression of putative membrane progestin receptor homologues in human endometrium and gestational tissues. J Endocrinol. 2005;187(1):89\u2013101","journal-title":"J Endocrinol"},{"issue":"2","key":"1907674_CR71","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.yfrne.2008.01.001","volume":"29","author":"P Thomas","year":"2008","unstructured":"Thomas P. Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Front Neuroendocrinol. 2008;29(2):292\u2013312","journal-title":"Front Neuroendocrinol"},{"issue":"6","key":"1907674_CR72","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0039-128X(01)00180-5","volume":"67","author":"P Thomas","year":"2002","unstructured":"Thomas P, Zhu Y, Pace M. Progestin membrane receptors involved in the meiotic maturation of teleost oocytes: a review with some new findings. Steroids. 2002;67(6):511\u2013517","journal-title":"Steroids"},{"issue":"9","key":"1907674_CR73","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1128\/MCB.20.9.3102-3115.2000","volume":"20","author":"PH Giangrande","year":"2000","unstructured":"Giangrande PH, Kimbrel EA, Edwards DP, McDonnell DP. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol. 2000;20(9):3102\u20133115","journal-title":"Mol Cell Biol"},{"issue":"11","key":"1907674_CR74","first-page":"4576","volume":"61","author":"RL Arnett-Mansfield","year":"2001","unstructured":"Arnett-Mansfield RL, deFazio A, Wain GV, et al. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res. 2001;61(11):4576\u20134582","journal-title":"Cancer Res"},{"issue":"3","key":"1907674_CR75","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ygyno.2008.10.032","volume":"112","author":"V Jongen","year":"2009","unstructured":"Jongen V, Briet J, de Jong R, et al. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer. Gynecol Oncol. 2009;112(3):537\u2013542","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1907674_CR76","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1023\/A:1014820500738","volume":"72","author":"PA Mote","year":"2002","unstructured":"Mote PA, Bartow S, Tran N, Clarke CL. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat. 2002;72(2):163\u2013172","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1907674_CR77","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1055\/s-0029-1242994","volume":"28","author":"L Aghajanova","year":"2010","unstructured":"Aghajanova L, Velarde MC, Giudice LC. Altered gene expression profiling in endometrium: evidence for progesterone resistance. Semin Reprod Med. 2010;28(1):51\u201358","journal-title":"Semin Reprod Med"},{"issue":"2 Pt 2","key":"1907674_CR78","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/AOG.0b013e3181719b92","volume":"112","author":"ZQ Shen","year":"2008","unstructured":"Shen ZQ, Zhu HT, Lin JF. Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives. Obstet Gynecol. 2008;112(2 Pt 2):465\u2013467","journal-title":"Obstet Gynecol"},{"issue":"6","key":"1907674_CR79","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1210\/jc.2010-2600","volume":"96","author":"RF Savaris","year":"2011","unstructured":"Savaris RF, Groll JM, Young SL, et al. Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citratetreated and artificial menstrual cycles. J Clin Endocrinol Metab. 2011;96(6):1737\u20131746","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1907674_CR80","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1095\/biolreprod.103.024786","volume":"70","author":"AA Kowalski","year":"2004","unstructured":"Kowalski AA, Vale-Cruz DS, Simmen FA, Simmen RC. Uterine androgen receptors: roles in estrogen-mediated gene expressionand DNA synthesis. Biol Reprod. 2004;70(5):1349\u20131357","journal-title":"Biol Reprod"},{"issue":"2","key":"1907674_CR81","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1210\/en.2004-1132","volume":"146","author":"PV Nantermet","year":"2005","unstructured":"Nantermet PV, Masarachia P, Gentile MA, et al. Androgenic induction of growth and differentiation in the rodent uterus involves the modulation of estrogen-regulated genetic pathways. Endocrinology. 2005;146(2):564\u2013578","journal-title":"Endocrinology"},{"key":"1907674_CR82","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1749-6632.1996.tb16231.x","volume":"784","author":"M Beato","year":"1996","unstructured":"Beato M, Truss M, Chavez S. Control of transcription by steroid hormones. Ann N Y Acad Sci. 1996;784:93\u2013123","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"1907674_CR83","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0960-0760(94)90115-5","volume":"51","author":"L Sahlin","year":"1994","unstructured":"Sahlin L, Norstedt G, Eriksson H. Androgen regulation of the insulin-like growth factor-I and the estrogen receptor in rat uterus and liver. J Steroid Biochem Mol Biol. 1994;51(1\u20132):57\u201366","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"1907674_CR84","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0960-0760(00)00127-8","volume":"74","author":"LP Lovely","year":"2000","unstructured":"Lovely LP, Appa Rao KB, Gui Y, Lessey BA. Characterization of androgen receptors in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa). J Steroid Biochem Mol Biol. 2000;74(4):235\u2013241","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"1907674_CR85","first-page":"165","volume":"78","author":"S Narukawa","year":"1994","unstructured":"Narukawa S, Kanzaki H, Inoue T, et al. Androgens induce prolactin production by human endometrial stromal cells in vitro. J Clin Endocrinol Metab. 1994;78(1):165\u2013168","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1907674_CR86","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1095\/biolreprod55.3.519","volume":"55","author":"X Zhang","year":"1996","unstructured":"Zhang X, Croy BA. Maintenance of decidual cell reaction by androgens in the mouse. Biol Reprod. 1996;55(3):519\u2013524","journal-title":"Biol Reprod"},{"issue":"6","key":"1907674_CR87","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774\u2013800","journal-title":"Endocr Rev"},{"issue":"5","key":"1907674_CR88","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","volume":"43","author":"EM Velazquez","year":"1994","unstructured":"Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism. 1994;43(5):647\u2013654","journal-title":"Metabolism"},{"issue":"4","key":"1907674_CR89","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ajog.2006.12.025","volume":"196","author":"RS Legro","year":"2007","unstructured":"Legro RS, Zaino RJ, Demers LM, et al. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome. Am J Obstet Gynecol. 2007;196(4):402 e1\u201310; discussion 402 e10-1","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1907674_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2008-0030","volume":"30","author":"S Palomba","year":"2009","unstructured":"Palomba S, Falbo A, Zullo F, Orio F Jr. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev. 2009;30(1):1\u201350","journal-title":"Endocr Rev"},{"issue":"8","key":"1907674_CR91","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1210\/jc.2003-032028","volume":"89","author":"R Mioni","year":"2004","unstructured":"Mioni R, Chiarelli S, Xamin N, et al. Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients. J Clin Endocrinol Metab. 2004;89(8):4089\u20134096","journal-title":"J Clin Endocrinol Metab"},{"key":"1907674_CR92","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1196\/annals.1335.038","volume":"1034","author":"B Mozzanega","year":"2004","unstructured":"Mozzanega B, Mioni R, Granzotto M, et al. Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome. Ann N Y Acad Sci. 2004;1034:364\u2013374","journal-title":"Ann N Y Acad Sci"},{"key":"1907674_CR93","doi-asserted-by":"crossref","unstructured":"Kouidhi S, Berrhouma R, Rouissi K, Jarboui S, Clerget-Froidevaux MS, Seugnet I, Bchir F, Demeneix B, Guissouma H, Elgaaied AB. Human subcutaneous adipose tissue Glut 4 mRNA expression in obesity and type 2 diabetes. Acta Diabetol. 2011 May 22. [Epub ahead of print]","DOI":"10.1007\/s00592-011-0295-8"},{"issue":"1","key":"1907674_CR94","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/157339907779802067","volume":"3","author":"MA Jay","year":"2007","unstructured":"Jay MA, Ren J. Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. Curr Diabetes Rev. 2007;3(1):33\u201339","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"1907674_CR95","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1530\/REP-10-0056","volume":"140","author":"K Kohan","year":"2010","unstructured":"Kohan K, Carvajal R, Gabler F, et al. Role of the transcriptional factors FOXO1 and PPARG on gene expression of SLC2A4 in endometrial tissue from women with polycystic ovary syndrome. Reproduction. 2010;140(1):123\u2013131","journal-title":"Reproduction"},{"issue":"40","key":"1907674_CR96","doi-asserted-by":"publisher","first-page":"27208","DOI":"10.1074\/jbc.M804282200","volume":"283","author":"VK Randhawa","year":"2008","unstructured":"Randhawa VK, Ishikura S, Talior-Volodarsky I, et al. GLUT4 vesicle recruitment and fusion are differentially regulated by Rac, AS160, and Rab8A in muscle cells J Biol Chem. 2008;283(40):27208\u201327219.","journal-title":"J Biol Chem"},{"issue":"3","key":"1907674_CR97","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1507\/endocrj.KR-65","volume":"53","author":"M Kanzaki","year":"2006","unstructured":"Kanzaki M. Insulin receptor signals regulating GLUT4 translocation and actin dynamics. Endocr J. 2006;53(3):267\u2013293","journal-title":"Endocr J"},{"issue":"1","key":"1907674_CR98","doi-asserted-by":"publisher","first-page":"E38","DOI":"10.1152\/ajpendo.90306.2008","volume":"295","author":"E Karnieli","year":"2008","unstructured":"Karnieli E, Armoni M. Transcriptional regulation of the insulinresponsive glucose transporter GLUT4 gene: from physiology to pathology. Am J Physiol Endocrinol Metab. 2008;295(1): E38\u2013E45","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"1907674_CR99","doi-asserted-by":"publisher","first-page":"394","DOI":"10.2337\/db06-0823","volume":"56","author":"L JeBailey","year":"2007","unstructured":"JeBailey L, Wanono O, Niu W, et al. Ceramide- and oxidantinduced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells. Diabetes. 2007;56(2):394\u2013403","journal-title":"Diabetes"},{"issue":"11","key":"1907674_CR100","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1093\/humrep\/deq232","volume":"25","author":"C Rosas","year":"2010","unstructured":"Rosas C, Gabler F, Vantman D, Romero C, Vega M. Levels of Rabs and WAVE family proteins associated with translocation of GLUT4 to the cell surface in endometria from hyperinsulinemic PCOS women. Hum Reprod. 2010;25(11):2870\u20132877","journal-title":"Hum Reprod"},{"issue":"3\u20134","key":"1907674_CR101","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2119\/molmed.2009.00118","volume":"16","author":"R Fornes","year":"2010","unstructured":"Fornes R, Ormazabal P, Rosas C, et al. Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia. Mol Med. 2010;16(3\u20134):129\u2013136","journal-title":"Mol Med"},{"issue":"10","key":"1907674_CR102","first-page":"767","volume":"45","author":"XR Song","year":"2010","unstructured":"Song XR, Zhang HY, Zhang YF, Han YK, Li KJ. Extracellular signal-regulated protein kinase activation in endometrium with polycystic ovary syndrome and its significance [in Chinese]. Zhonghua Fu Chan Ke Za Zhi. 2010;45(10):767\u2013771","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"4","key":"1907674_CR103","doi-asserted-by":"publisher","first-page":"221","DOI":"10.14310\/horm.2002.11130","volume":"3","author":"PA Essah","year":"2004","unstructured":"Essah PA, Cheang KI, Nestler JE. The pathophysiology of miscarriage in women with polycystic ovary syndrome. Review and proposed hypothesis of mechanisms involved. Hormones (Athens). 2004;3(4):221\u2013227","journal-title":"Hormones (Athens)"},{"issue":"6655","key":"1907674_CR104","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1136\/bmj.297.6655.1027","volume":"297","author":"M Sagle","year":"1988","unstructured":"Sagle M, Bishop K, Ridley N, et al. Recurrent early miscarriage and polycystic ovaries. BMJ. 1988;297(6655):1027\u20131028","journal-title":"BMJ"},{"issue":"5","key":"1907674_CR105","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.bpobgyn.2004.06.001","volume":"18","author":"ZM van der Spuy","year":"2004","unstructured":"van der Spuy ZM, Dyer SJ. The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):755\u2013771","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"1907674_CR106","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1471-0528.1993.tb12978.x","volume":"100","author":"M Tulppala","year":"1993","unstructured":"Tulppala M, Stenman UH, Cacciatore B, Ylikorkala O. Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women. Br J Obstet Gynaecol. 1993;100(4):348\u2013352","journal-title":"Br J Obstet Gynaecol"},{"issue":"6521","key":"1907674_CR107","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/374460a0","volume":"374","author":"I Satokata","year":"1995","unstructured":"Satokata I, Benson G, Maas R. Sexually dimorphic sterility phenotypes in Hoxa10-deficient mice. Nature. 1995;374(6521):460\u2013463","journal-title":"Nature"},{"issue":"16","key":"1907674_CR108","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/sj.gt.3301245","volume":"7","author":"CN Bagot","year":"2000","unstructured":"Bagot CN, Troy PJ, Taylor HS. Alteration of maternal Hoxa10 expression by in vivo gene transfection affects implantation. Gene Ther. 2000;7(16):1378\u20131384","journal-title":"Gene Ther"},{"issue":"7","key":"1907674_CR109","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1172\/JCI1597","volume":"101","author":"HS Taylor","year":"1998","unstructured":"Taylor HS, Arici A, Olive D, Igarashi P. HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest. 1998;101(7):1379\u20131384","journal-title":"J Clin Invest"},{"issue":"3","key":"1907674_CR110","first-page":"571","volume":"16","author":"GS Daftary","year":"2002","unstructured":"Daftary GS, Troy PJ, Bagot CN, Young SL, Taylor HS. Direct regulation of beta3-integrin subunit gene expression by HOXA10 in endometrial cells. Mol Endocrinol. 2002;16(3):571\u2013579","journal-title":"Mol Endocrinol"},{"issue":"5","key":"1907674_CR111","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1095\/biolreprod62.5.1285","volume":"62","author":"MJ Illera","year":"2000","unstructured":"Illera MJ, Cullinan E, Gui Y, et al. Blockade of the alpha(v)beta(3) integrin adversely affects implantation in the mouse. Biol Reprod. 2000;62(5):1285\u20131290","journal-title":"Biol Reprod"},{"issue":"1","key":"1907674_CR112","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1210\/jc.2002-021072","volume":"88","author":"D Cermik","year":"2003","unstructured":"Cermik D, Selam B, Taylor HS. Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88(1):238\u2013243","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1907674_CR113","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1172\/JCI115835","volume":"90","author":"BA Lessey","year":"1992","unstructured":"Lessey BA, Damjanovich L, Coutifaris C, et al. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle J Clin Invest. 1992;90(1):188\u2013195.","journal-title":"J Clin Invest"},{"issue":"11","key":"1907674_CR114","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1093\/humrep\/dep247","volume":"24","author":"L Margarit","year":"2009","unstructured":"Margarit L, Gonzalez D, Lewis PD, et al. L-selectin ligands in human endometrium: comparison of fertile and infertile subjects. Hum Reprod. 2009;24(11):2767\u20132777","journal-title":"Hum Reprod"},{"issue":"12","key":"1907674_CR115","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s10552-010-9658-7","volume":"21","author":"EJ Fearnley","year":"2010","unstructured":"Fearnley EJ, Marquart L, Spurdle AB, Weinstein P, Webb PM. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study. Cancer Causes Control. 2010;21(12):2303\u20132308","journal-title":"Cancer Causes Control"},{"issue":"3","key":"1907674_CR116","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S1472-6483(10)60175-7","volume":"19","author":"BG Chittenden","year":"2009","unstructured":"Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online. 2009;19(3):398\u2013405","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"1907674_CR117","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/09513590400021201","volume":"20","author":"A Gadducci","year":"2005","unstructured":"Gadducci A, Gargini A, Palla E, Fanucchi A, Genazzani AR. Polycystic ovary syndrome and gynecological cancers: is there a link? Gynecol Endocrinol. 2005;20(4):200\u2013208","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"1907674_CR118","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/humrep\/del407","volume":"22","author":"S Nader","year":"2007","unstructured":"Nader S, Diamanti-Kandarakis E. Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis. Hum Reprod. 2007;22(2):317\u2013322","journal-title":"Hum Reprod"},{"issue":"1","key":"1907674_CR119","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/GRF.0b013e31802f35a0","volume":"50","author":"S Dronavalli","year":"2007","unstructured":"Dronavalli S, Ehrmann DA. Pharmacologic therapy of polycystic ovary syndrome. Clin Obstet Gynecol. 2007;50(1):244\u2013254","journal-title":"Clin Obstet Gynecol"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719111430993.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719111430993","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719111430993\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719111430993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719111430993.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:22:39Z","timestamp":1656811359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719111430993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":119,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["1907674"],"URL":"https:\/\/doi.org\/10.1177\/1933719111430993","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"30 December 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}